搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
aldx
/
财务摘要
Aldeyra Therapeutics Inc
ALDX
添加自选
1.290
USD
-0.060
-4.44%
交易中 09/24, 12:57(美东)
77.81M
总市值
亏损
市盈率 TTM
Aldeyra Therapeutics Inc
1.290
-0.060
-4.44%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
ALDX 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Aldeyra Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
77.81M
股息TTM
0.00
市盈率 TTM
-2.83
每股收益TTM
-0.46
营业收入
--
净利润
-55.85M
净资产收益率
-51.76%
总资产收益率
-34.28%
Aldeyra Therapeutics Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.09
/-0.09
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
44.46%
-0.09
65.48%
-0.06
59.52%
-0.11
49.63%
-0.13
42.63%
-0.16
-21.88%
-0.17
-230.48%
-0.27
-82.93%
-0.25
-85.50%
-0.28
48.79%
-0.14
63.56%
-0.08
--
-0.14
--
-0.15
--
-0.27
--
-0.22
--
-0.84
--
--
--
--
--
--
--
--
净利润
44.20%
-5.45M
65.23%
-3.45M
59.13%
-6.46M
49.13%
-7.69M
42.03%
-9.77M
-22.86%
-9.93M
-232.61%
-15.81M
-84.60%
-15.11M
-87.47%
-16.85M
48.24%
-8.08M
63.16%
-4.75M
43.75%
-8.19M
49.46%
-8.99M
6.98%
-15.62M
18.11%
-12.90M
7.86%
-14.55M
-19.04%
-17.78M
-48.70%
-16.79M
-39.52%
-15.75M
-78.01%
-15.79M
资产负债率
-100.00%
0.00%
42.05%
23.01%
47.28%
21.16%
50.00%
19.54%
47.44%
17.83%
50.56%
16.20%
40.72%
14.37%
19.01%
13.02%
17.45%
12.09%
13.69%
10.76%
16.91%
10.21%
--
10.94%
--
10.30%
--
9.47%
--
8.73%
--
8.30%
--
--
--
--
--
--
--
--
利润表
营业利润
42.47%
-5.85M
65.98%
-3.55M
59.78%
-6.67M
50.42%
-8.00M
43.53%
-10.17M
-11.00%
-10.43M
-171.87%
-16.58M
-68.97%
-16.14M
-74.11%
-18.01M
44.10%
-9.39M
55.48%
-6.10M
35.40%
-9.55M
41.62%
-10.34M
-1.94%
-16.80M
11.08%
-13.70M
4.25%
-14.78M
-21.81%
-17.71M
-52.19%
-16.48M
-61.58%
-15.40M
-84.06%
-15.44M
净利润
44.20%
-5.45M
65.23%
-3.45M
59.13%
-6.46M
49.13%
-7.69M
42.03%
-9.77M
-22.86%
-9.93M
-232.61%
-15.81M
-84.60%
-15.11M
-87.47%
-16.85M
48.24%
-8.08M
63.16%
-4.75M
43.75%
-8.19M
49.46%
-8.99M
6.98%
-15.62M
18.11%
-12.90M
7.86%
-14.55M
-19.04%
-17.78M
-48.70%
-16.79M
-39.52%
-15.75M
-78.01%
-15.79M
资产负债表
流动资产
-43.97%
47.38M
-28.53%
66.27M
-31.03%
71.78M
-33.64%
77.46M
-32.70%
84.56M
-34.16%
92.73M
-29.59%
104.07M
-20.71%
116.72M
-19.19%
125.65M
-16.17%
140.85M
-18.35%
147.81M
-22.31%
147.21M
-22.55%
155.48M
-24.44%
168.02M
-22.23%
181.02M
-23.22%
189.48M
-21.67%
200.74M
51.19%
222.36M
180.22%
232.75M
179.81%
246.77M
流动负债总额
-67.31%
9.66M
70.28%
24.33M
49.50%
27.81M
66.05%
28.48M
7.02%
29.53M
-34.10%
14.29M
-16.43%
18.60M
-20.65%
17.15M
76.83%
27.59M
35.41%
21.68M
44.92%
22.26M
-10.65%
21.62M
-3.93%
15.61M
-2.12%
16.01M
30.48%
15.36M
102.60%
24.20M
119.23%
16.24M
47.46%
16.35M
-5.13%
11.77M
84.84%
11.94M
总资产
-44.05%
47.54M
-28.66%
66.48M
-31.11%
72.06M
-33.68%
77.80M
-32.59%
84.96M
-34.04%
93.20M
-29.48%
104.61M
-20.34%
117.32M
-19.00%
126.04M
-16.00%
141.30M
-18.18%
148.33M
-22.36%
147.28M
-22.58%
155.62M
-24.46%
168.22M
-22.24%
181.29M
-23.27%
189.69M
-21.61%
201.02M
51.18%
222.69M
179.70%
233.14M
179.90%
247.22M
总负债
-67.46%
9.66M
-17.81%
24.33M
-17.24%
27.81M
-11.38%
28.56M
7.00%
29.67M
6.15%
29.60M
17.77%
33.60M
32.75%
32.22M
7.77%
27.73M
-9.99%
27.88M
-5.78%
28.53M
-11.72%
24.27M
-4.64%
25.73M
-3.21%
30.98M
10.52%
30.28M
-0.18%
27.50M
18.64%
26.99M
50.74%
32.00M
14.92%
27.40M
43.82%
27.55M
总权益
-31.48%
37.89M
-33.71%
42.16M
-37.68%
44.25M
-42.13%
49.24M
-43.76%
55.29M
-43.93%
63.60M
-40.73%
71.00M
-30.82%
85.10M
-24.31%
98.31M
-17.36%
113.42M
-20.67%
119.80M
-24.16%
123.01M
-25.37%
129.88M
-28.03%
137.24M
-26.60%
151.01M
-26.16%
162.19M
-25.53%
174.03M
51.25%
190.69M
245.72%
205.74M
217.58%
219.67M
现金流量表
经营净额
46.36%
-4.59M
59.02%
-5.11M
55.97%
-5.30M
11.96%
-7.02M
35.31%
-8.56M
-25.04%
-12.47M
-2505.25%
-12.04M
0.62%
-7.97M
1.00%
-13.22M
-5.60%
-9.97M
104.46%
500.44K
36.18%
-8.02M
33.07%
-13.36M
26.64%
-9.44M
2.99%
-11.23M
-49.09%
-12.57M
-119.99%
-19.96M
4.44%
-12.87M
-39.20%
-11.58M
-35.22%
-8.43M
投资净额
95.83%
-23.10K
-100.00%
0.00
1123.10%
16.00M
375.05%
25.00M
96.96%
-554.13K
124.00%
7.29M
--
-1.56M
--
5.26M
--
-18.24M
-201.26%
-30.38M
-100.00%
0.00
-100.00%
0.00
100.00%
0.00
151.70%
30.00M
--
27.00M
--
19.02M
--
-17.94M
-743325.39%
-58.03M
--
0.00
-100.00%
0.00
融资净额
--
-15.30M
-92.91%
71.14K
-100.00%
0.00
161.17%
120.75K
--
0.00
5412.67%
1.00M
100.77%
7.78K
37.49%
-197.39K
-100.00%
0.00
-65.39%
18.19K
--
-1.01M
-126.38%
-315.76K
--
5.29K
125.34%
52.56K
--
0.00
1776.46%
1.20M
-100.00%
0.00
-99.97%
23.32K
-100.00%
0.00
-99.76%
63.78K
常见问题
Aldeyra Therapeutics Inc的流动资产是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,流动资产为71.78M(同比变化-31.03)。
Aldeyra Therapeutics Inc的总资产是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的总资产为72.06M(同比变化-31.11)。
Aldeyra Therapeutics Inc的总负债是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的总负债为27.81M(同比变化-17.24)。
Aldeyra Therapeutics Inc的总权益是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的总权益为44.25M(同比变化-37.68)。
Aldeyra Therapeutics Inc的净营业收入是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的净营业收入为-35.27M(同比变化41.34)。
Aldeyra Therapeutics Inc的净投资是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的净投资为47.74M(同比变化206.28)。
Aldeyra Therapeutics Inc的净融资是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,Aldeyra Therapeutics Inc的净融资为1.12M(同比变化755.43)。
Aldeyra Therapeutics Inc的每股收益(EPS)是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.56(同比变化39.98)。
Aldeyra Therapeutics Inc的净利润是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,净利润为-33.85M(同比变化39.40)。
Aldeyra Therapeutics Inc的债务与资产比率是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,债务与资产比率为21.16(同比变化47.28)。
Aldeyra Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-58.73(同比变化-0.32)。
Aldeyra Therapeutics Inc的资产回报率(ROA)是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,资产回报率(ROA)为-38.32(同比变化13.24)。
Aldeyra Therapeutics Inc的营业利润是多少?
根据Aldeyra Therapeutics Inc的FY2025财报,营业利润为-35.27M(同比变化41.34)。